摘要
背景与目的:目前的流行病学研究报告了他汀类药物或二甲双胍对胰腺癌整体生存率的影响。本文通过文献综述和Meta分析,总结了有关胰腺癌患者使用他汀类药物或二甲双胍与患者整体生存率之间的关系的研究成果。方法:在计算机数据库(PubMed、ISI Web of Science、MEDLINE、Cochrane、Scopus、Google学者)中,系统地研究了他汀类和二甲双胍类药物与胰腺癌整体生存率的关系。采用随机效应模型,基于危险比(HRs)和95%置信区间(CIS)进行元分析。采用I2统计量检验研究之间的异质性,并进行敏感性分析,以评估研究结果的稳健性。结果:在所鉴定的116篇与他汀类相关的文章中,有6篇涉及12,057例患者的回顾性队列研究。研究之间存在显著的异质性。胰腺癌患者应用他汀类药物可提高生存率(Meta-HR=0.75;95%CI:0.59,0.90;P<0.001)。在311篇与二甲双胍有关的文章中,8项回顾性队列研究和2项随机临床试验,代表3,042名患者。二甲双胍的使用与胰腺癌患者的总生存期有关(Meta-HR=0.79;95%CI:0.70,0.92,P<0.001)。结论:胰腺癌患者生存时间的改善与他汀类药物或二甲双胍的使用有关。由于原始研究的多个来源的异质性,这些发现应慎重考虑,并与更大的前瞻性个人水平的研究证实。
关键词: 他汀类,二甲双胍,胰腺癌,总生存率,Meta分析,癌症药物。
Current Medicinal Chemistry
Title:Effect of Metformin and Statin Use on Survival in Pancreatic Cancer Patients: a Systematic Literature Review and Meta-analysis
Volume: 25 Issue: 22
关键词: 他汀类,二甲双胍,胰腺癌,总生存率,Meta分析,癌症药物。
摘要: Background and Objective: Current epidemiological studies report conflicting results for the effect of statin or metformin on pancreatic cancer overall survival. This literature review and meta-analysis summarize the studies reporting an association between statin or metformin use and overall survival of pancreatic cancer patients.
Methods: We systematically searched for studies about the association between statin or metformin use and pancreatic cancer overall survival in electronic databases (PubMed, ISI Web of Science, MEDLINE, Cochrane, Scopus, Google Scholar). A meta-analysis based on hazard ratios (HRs) and 95% confidence intervals (CIs) was performed using random effect models. Heterogeneity between the studies was examined using I2 statistics, and sensitivity analyses were conducted to assess the robustness of the findings.
Results: Of 116 statin-related articles identified, 6 retrospective cohort studies representing 12,057 patients were included. There was significant heterogeneity between studies. Statin use was associated with improved survival among pancreatic cancer patients (meta-HR = 0.75; 95% CI: 0.59, 0.90; P < 0.001). Of 311 metformin-related articles, 8 retrospective cohort studies and 2 randomized clinical trials, representing 3,042 patients were identified. Metformin use was associated with better overall survival among pancreatic cancer patients (meta-HR = 0.79; 95% CI: 0.70, 0.92, P < 0.001), and significant heterogeneity was observed between studies.
Conclusion: Our findings suggest that the improved survival time of pancreatic cancer patients are associated with statin or metformin use. Due to the multiple sources of heterogeneity of the original studies, these findings should be considered cautiously, and confirmed with larger prospective individual-level studies.
Export Options
About this article
Cite this article as:
Effect of Metformin and Statin Use on Survival in Pancreatic Cancer Patients: a Systematic Literature Review and Meta-analysis, Current Medicinal Chemistry 2018; 25 (22) . https://dx.doi.org/10.2174/0929867324666170412145232
DOI https://dx.doi.org/10.2174/0929867324666170412145232 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
MicroRNA Gene Networks in Oncogenesis
Current Genomics Synthetic 2-Methoxyestradiol Derivatives: Structure-Activity Relationships
Current Medicinal Chemistry An Overview on the Pharmacokinetics of Quantum Dots
Current Drug Metabolism Protein Kinases and Associated Pathways in Pluripotent State and Lineage Differentiation
Current Stem Cell Research & Therapy The Quest for Novel Biomarkers in Early Diagnosis of Diabetic Neuropathy
Current Proteomics Differential Splicing, Disease and Drug Targets
Infectious Disorders - Drug Targets Oxidative Stress Biology and Cell Injury During Type 1 and Type 2 Diabetes Mellitus
Current Neurovascular Research Molecular Mechanism of P-glycoprotein Assembly into Cellular Membranes
Current Protein & Peptide Science MR Imaging Findings of Uterine Cervical Carcinoma
Current Medical Imaging The Anabolic Effects of Growth Hormone (GH) and GH Secretagogues on Bone Mass and Density
Medicinal Chemistry Reviews - Online (Discontinued) Patent Analysis as a Tool for Research Planning: Study on Natural Based Therapeutics Against Cancer Stem Cells
Recent Patents on Anti-Cancer Drug Discovery Sleep Duration as a Risk Factor for Cardiovascular Disease- a Review of the Recent Literature
Current Cardiology Reviews The Coordinated Role of CYP450 Enzymes and P-gp in Determining Cancer Resistance to Chemotherapy
Current Drug Metabolism The Role of ABC and SLC Transporters in the Pharmacokinetics of Dietary and Herbal Phytochemicals and their Interactions with Xenobiotics
Current Drug Metabolism The Role of Ghrelin Signals in Breast Cancer- A Systematic Review
Current Signal Transduction Therapy microRNA Biogenesis Pathway as a Therapeutic Target for Human Disease and Cancer
Current Pharmaceutical Design In vitro Lipolysis: An Indispensable Tool for the Development of IVIVC of Lipid Based Drug Delivery Systems
Drug Delivery Letters Small-Molecule Inhibitors of Bcl-2 Family Proteins as Therapeutic Agents in Cancer
Recent Patents on Anti-Cancer Drug Discovery The Use of Small Peptides in the Diagnosis and Treatment of Hepatocellular Carcinoma
Protein & Peptide Letters Glioblastoma Stem-Like Cells – Isolation, Biology and Mechanisms of Chemotherapy Resistance
Current Signal Transduction Therapy